1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Factors affecting the uptake of screening for neural tube defect
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1988.tb09483.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 95, Issue 6, pages 560–564, June 1988
Additional Information
How to Cite
KYLE, D., CUMMINS, C. and EVANS, S. (1988), Factors affecting the uptake of screening for neural tube defect. BJOG: An International Journal of Obstetrics & Gynaecology, 95: 560–564. doi: 10.1111/j.1471-0528.1988.tb09483.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 1 June 1987, Accepted 11 September 1987
- Abstract
- References
- Cited By
Summary. A questionnaire concerning pregnant women's knowledge of, and attitudes to, serum alpha fetoprotein (AFP) screening for spina bifida was sent to all pregnant women receiving a health education leaflet on AFP screening who booked at the Birmingham Maternity Hospital in the first quarter of 1984. The majority said that they would accept the test, and subsequently did so. This suggests that low uptake of the test is not a result of patients' resistance, and the results indicated that the provision of early information about the test is likely to improve uptake and decrease anxiety. With the increasing clinical usefulness of the AFP test, routine screening of pregnant women with an ‘opt-out’ system is becoming clinically desirable, and the survey suggests that it would be acceptable to the patients.